Katie J Ewer Selected Research

1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)

1/2018	Safety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP.
9/2016	Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP.
4/2015	Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals.
4/2014	Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection.
1/2014	Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposure.
1/2013	Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katie J Ewer Research Topics

Disease

34	Malaria 02/2024 - 01/2011
21	Infections 01/2023 - 06/2007
7	COVID-19 11/2022 - 01/2020
6	Vaccinia 03/2021 - 11/2014
5	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2021 - 12/2011
3	Pain (Aches) 02/2024 - 01/2020
3	Fever (Fevers) 02/2024 - 01/2021
3	Bites and Stings (Sting) 01/2018 - 12/2012
2	Headache (Headaches) 12/2021 - 01/2020
2	Ageusia (Hypogeusia) 10/2021 - 01/2021
2	Dyspnea (Shortness of Breath) 10/2021 - 01/2021
2	Anosmia 10/2021 - 01/2021
2	Cough 10/2021 - 01/2021
2	Human Influenza (Influenza) 03/2019 - 01/2011
2	Ebola Hemorrhagic Fever 01/2019 - 05/2017
2	Communicable Diseases (Infectious Diseases) 07/2018 - 01/2013
1	Rift Valley Fever 01/2023
1	Rabies (Hydrophobia) 01/2022
1	HIV Infections (HIV Infection) 01/2021
1	Chills 01/2020
1	Herpes Zoster 07/2018
1	Meningitis 07/2018
1	Parasitic Diseases (Parasitic Disease) 09/2016
1	Parasitemia 01/2014
1	Bovine Tuberculosis 06/2007
1	Tuberculosis (Tuberculoses) 06/2007

Drug/Important Bio-Agent (IBA)

44	VaccinesIBA 02/2024 - 01/2011
17	AntigensIBA 11/2022 - 01/2011
15	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2011
8	ChAdOx1 nCoV-19IBA 01/2023 - 01/2020
6	Malaria VaccinesIBA 02/2024 - 12/2012
6	AntibodiesIBA 01/2023 - 12/2012
6	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 01/2018 - 01/2013
6	ThrombospondinsIBA 01/2018 - 01/2013
5	Merozoite Surface Protein 1 (MSA1)IBA 04/2014 - 12/2011
4	Matrix-MIBA 02/2024 - 01/2021
4	EpitopesIBA 01/2018 - 01/2013
3	Rabies Vaccines (Rabies Vaccine)FDA Link 12/2022 - 01/2016
3	Nucleic AcidsIBA 10/2021 - 01/2021
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2022
2	MenACWYIBA 10/2021 - 01/2020
2	Ebola VaccinesIBA 01/2020 - 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2023
1	rabivaxIBA 12/2022
1	Neutralizing AntibodiesIBA 01/2021
1	asparaginyl-prolineIBA 01/2021
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020
1	4CMenB vaccineIBA 07/2018
1	Antimalarials (Antimalarial Agents)IBA 01/2016
1	Peptides (Polypeptides)IBA 02/2013
1	LigandsIBA 02/2013
1	Subunit VaccinesIBA 01/2013
1	Recombinant ProteinsIBA 01/2012
1	Interleukin-4 (Interleukin 4)IBA 06/2007
1	Messenger RNA (mRNA)IBA 06/2007

Therapy/Procedure

1	Intramuscular Injections 01/2020
1	Immunotherapy 01/2018